Rodent models of leptin receptor-deficiency are less sensitive to amylin.

The pancreatic hormone amylin is released from beta cells following nutrient ingestion and contributes to the control of body weight and glucose homeostasis. Amylin reduces food intake by activating neurons in the area postrema (AP). Amylin was also shown to synergize with the adipokine, leptin, with combination therapy producing greater weight loss and food intake reduction than either hormone alone. While amylin and leptin were initially thought to interact downstream of the AP in the hypothalamus, recent findings show that the two hormones can act on the same AP neurons, suggesting a more direct relationship. The objective of this study was to determine whether amylin action depends on functional leptin signaling. We tested amylin's ability to induce satiation and to activate its primary target neurons in the AP in two rodent models of LepR-deficiency, the db/db mouse and the Zucker diabetic fatty (ZDF) rat. Compared to wild type (WT) mice, db/db mice exhibited reduced amylin-induced satiation, reduced amylin-induced Fos in the AP, and a lower expression of calcitonin receptor (CTR) protein, the core component of the amylin receptor. ZDF rats also showed no reduction in food intake following amylin treatment, however, unlike the db/db mice, levels of amylin-induced Fos and CTR in the AP were no different than WT rats. Our results suggest that LepR expression is required for the full anorexic effect of amylin, however, the neuronal activation in the AP seems to depend on the type of LepR mutation.